MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 230 filers reported holding MYRIAD GENETICS INC in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $878,078 | -58.9% | 54,743 | -40.6% | 0.01% | -58.8% |
Q2 2023 | $2,136,895 | +7.2% | 92,187 | +7.4% | 0.02% | 0.0% |
Q1 2023 | $1,993,157 | +158338.6% | 85,801 | -1.1% | 0.02% | +54.5% |
Q4 2022 | $1,258 | -99.9% | 86,725 | +18.0% | 0.01% | -21.4% |
Q3 2022 | $1,402,000 | +5.3% | 73,468 | +0.3% | 0.01% | 0.0% |
Q2 2022 | $1,331,000 | -23.3% | 73,241 | +6.4% | 0.01% | -17.6% |
Q1 2022 | $1,735,000 | +4.1% | 68,843 | +14.1% | 0.02% | 0.0% |
Q4 2021 | $1,666,000 | -12.8% | 60,355 | +2.0% | 0.02% | -22.7% |
Q3 2021 | $1,911,000 | +5.7% | 59,182 | +0.1% | 0.02% | +10.0% |
Q2 2021 | $1,808,000 | +2.4% | 59,131 | +1.9% | 0.02% | -9.1% |
Q1 2021 | $1,766,000 | +53.3% | 58,002 | -0.4% | 0.02% | +37.5% |
Q4 2020 | $1,152,000 | +52.4% | 58,262 | +0.5% | 0.02% | +6.7% |
Q3 2020 | $756,000 | +77.5% | 57,972 | +54.5% | 0.02% | +87.5% |
Q2 2020 | $426,000 | -20.5% | 37,529 | +0.3% | 0.01% | -33.3% |
Q1 2020 | $536,000 | -22.0% | 37,427 | +48.4% | 0.01% | 0.0% |
Q4 2019 | $687,000 | -4.2% | 25,219 | +0.7% | 0.01% | -7.7% |
Q3 2019 | $717,000 | +2.7% | 25,054 | -0.3% | 0.01% | +8.3% |
Q2 2019 | $698,000 | -16.4% | 25,130 | -0.1% | 0.01% | -20.0% |
Q1 2019 | $835,000 | +12.1% | 25,148 | -1.9% | 0.02% | 0.0% |
Q4 2018 | $745,000 | -4.4% | 25,636 | +51.4% | 0.02% | +36.4% |
Q3 2018 | $779,000 | +40.9% | 16,931 | +14.5% | 0.01% | +57.1% |
Q2 2018 | $553,000 | – | 14,787 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |